Ledger.Open graph →
SEC Form D · filed September 25, 2013

Tyrosine Pharma Inc

Offering
$250K
Sold
$100K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Albuquerque, NM
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Wayne Laslie · Albuquerque, NMExec · DirectorAlan Kolod · Albuquerque, NMExecSteve T. Rhodes · M.P. Misgav, L3Exec · DirectorRobert T. Kittel · Toronto, Ontario, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗